Compare ABCL & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | INNV |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2020 | 2021 |
| Metric | ABCL | INNV |
|---|---|---|
| Price | $4.21 | $8.29 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 5 | 1 |
| Target Price | ★ $8.40 | $7.00 |
| AVG Volume (30 Days) | ★ 4.0M | 222.8K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.91 | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | $75,128,000.00 | ★ $853,699,000.00 |
| Revenue This Year | N/A | $12.85 |
| Revenue Next Year | $21.85 | $8.88 |
| P/E Ratio | ★ N/A | $57.61 |
| Revenue Growth | ★ 160.56 | 11.76 |
| 52 Week Low | $1.94 | $2.84 |
| 52 Week High | $6.52 | $10.69 |
| Indicator | ABCL | INNV |
|---|---|---|
| Relative Strength Index (RSI) | 70.31 | 52.70 |
| Support Level | $3.91 | $7.57 |
| Resistance Level | $4.76 | $8.63 |
| Average True Range (ATR) | 0.21 | 0.33 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 83.66 | 61.06 |
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.